Inhibitors of histone acetylation may constitute a novel class of potent therapy sensitizers applicable to a broad range of conventional cancer treatments.
Multisubstrate Inhibitors of Histone Acetylation Increase the Cytotoxicity of Chemotherapeutic Agents
Category:
Therapeutics
Field of Use:
Oncology
Modality:
Small Molecule
Research Tool Type:
Assays/Screening